<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-59700</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Our experience with infliximab in reclacitrant cases of psoriasis</dc:title>
<dc:description xml:lang="en">Present report is focused in our personal experience with the anti TNF-&amp;#945; infliximab. There is a short, four case series, but they are a very representative sample of the clinical conditions that we can solve with infliximab (AU)</dc:description>
<dc:creator>González-Vilas, D</dc:creator>
<dc:creator>Sánchez-Aguilar, D</dc:creator>
<dc:creator>Pereiro, M</dc:creator>
<dc:creator>Toribio, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En el presente artículo, detallamos nuestra experiencia personal con el anticuerpo TNF-&amp;#945; (factor de necrosis tumoral alfa), infliximab. Se trata de cuatro casos que creemos que ilustran adecuadamente varias de las situaciones con las que nos podemos encontrar en el manejo de pacientes con psoriasis y algunos de los contextos clínicos en los que podemos recurrir a infliximab (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;99(supl.4): 43-47, jul. 2008. ilus</dc:source>
<dc:identifier>ibc-59700</dc:identifier>
<dc:title xml:lang="es">Nuestra experiencia con infliximab en psoriasis recalcitrante</dc:title>
<dc:subject>^d29623</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12002^s22016</dc:subject>
<dc:subject>^d12002^s22057</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d12002^s22012</dc:subject>
<dc:subject>^d12137^s22074</dc:subject>
<dc:subject>^d1184^s22012</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d29591^s22073</dc:subject>
<dc:subject>^d1184^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d29591^s22002</dc:subject>
<dc:subject>^d29591^s22000</dc:subject>
<dc:subject>^d29591^s22044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200807</dc:date>
</metadata>
</record>
</ibecs-document>
